-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AbxUkm3jhgfUSpAweRKZoc0mKTO9rW81wbsLz+H6/rkxNIG1AGB77PNzeG9od8SP J6xKb9wkCDHJp31USSYRUg== 0000950162-04-000744.txt : 20040617 0000950162-04-000744.hdr.sgml : 20040617 20040617164245 ACCESSION NUMBER: 0000950162-04-000744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040615 FILED AS OF DATE: 20040617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELAN PHARMACEUTICAL INVESTMENTS LTD CENTRAL INDEX KEY: 0001279105 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 04869159 MAIL ADDRESS: STREET 1: 102 ST JAMES COURT CITY: FIETSS SMITH FL BERMUDA STATE: D0 ZIP: 9999999999 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELAN INTERNATIONAL SERVICES LTD CENTRAL INDEX KEY: 0001002782 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 04869160 BUSINESS ADDRESS: STREET 1: 102 JAMES COURT FLATTS STREET 2: SMITH PARISH FL 04 CITY: BERMUDA STATE: D0 ZIP: 00000 BUSINESS PHONE: 4412929169 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7620 S W BRIDGEPORT RD CITY: PORTLAND STATE: OR ZIP: 97224 BUSINESS PHONE: 5036397221 MAIL ADDRESS: STREET 1: 7620 S W BRIDGEPORT ROAD CITY: PORTLAND STATE: OR ZIP: 97224 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELAN CORP PLC CENTRAL INDEX KEY: 0000737572 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 04869161 BUSINESS ADDRESS: STREET 1: LINCOLN HOUSE STREET 2: LINCOLN PLACE CITY: DUBLIN 2 STATE: L2 BUSINESS PHONE: 35317094000 MAIL ADDRESS: STREET 1: LINCOLN HOUSE STREET 2: LINCOLN PLACE CITY: DUBLIN 2 STATE: L2 ZIP: 00000 4 1 biojectform4061704_ex.xml X0202 4 2004-06-15 1 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0000737572 ELAN CORP PLC LINCOLN HOUSE LINCOLN PLACE DUBLIN 2 L2 IRELAND 0 0 1 0 0001002782 ELAN INTERNATIONAL SERVICES LTD 102 JAMES COURT FLATTS SMITH PARISH FL 04 BERMUDA D0 00000 0 0 1 0 0001279105 ELAN PHARMACEUTICAL INVESTMENTS LTD 102 ST. JAMES COURT FLATTS, SMITH FL 04 D0 BERMUDA 0 0 1 0 Common Stock 2004-06-15 4 S 0 2036148 1.96 D 347788 I I The securities are beneficially owned indirectly by Elan Corporation, plc and by its wholly-owned subsidiary, Elan International Services, Ltd., and directly by Elan Pharmaceutical Investments, Ltd., a wholly-owned subsidiary of Elan International Services, Ltd. Exhibit List Exhibit 99 - Joint Filer Information /s/ William F. Daniel 2004-06-17 EX-99 2 biojectform4061704ex99.txt JOINT FILER INFORMATION Exhibit 99 Joint Filer Information Name: Elan International Services, Ltd. Address: 102 St. James Court Flatts, Smiths FL 04 Bermuda Designated Filer: Elan Corporation, plc Issuer & Ticker Symbol: Bioject Medical Technologies, Inc. (BJCT) Date of Earliest Transaction Required to be Reported: 6/15/04 Signature: /s/ Kevin Insley ----------------------------------------------- Name: Kevin Insley Title: President and Chief Financial Officer ELAN INTERNATIONAL SERVICES, LTD. Joint Filer Information Name: Elan Pharmaceutical Investments, Ltd. Address: 102 St. James Court Flatts, Smiths FL 04 Bermuda Designated Filer: Elan Corporation, plc Issuer & Ticker Symbol: Bioject Medical Technologies, Inc. (BJCT) Date of Event Requiring Statement: 6/15/04 Signature: /s/ Kevin Insley ---------------------------------------------- Name: Kevin Insley Title: President and Chief Financial Officer ELAN PHARMACEUTICAL INVESTMENTS, LTD. -----END PRIVACY-ENHANCED MESSAGE-----